Biomarkers in lysosomal storage diseases: a review
- 1 March 2005
- journal article
- review article
- Published by Wiley in Acta Paediatrica
- Vol. 94, 39-42
- https://doi.org/10.1080/08035320510028085
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Is globotriaosylceramide a useful biomarker in Fabry disease?Acta Paediatrica, 2005
- Treatment with miglustat reverses the lipid-trafficking defect in Niemann–Pick disease type CNeurobiology of Disease, 2004
- How Industry Is Approaching the Search for New Diagnostic Markers and BiomarkersMolecular & Cellular Proteomics, 2004
- Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic interventionBlood, 2004
- Niemann–Pick disease type CClinical Genetics, 2003
- Biochemistry of glycosphingolipid storage disorders: implications for therapeutic interventionPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2003
- Critical role for glycosphingolipids in Niemann-Pick disease type CCurrent Biology, 2001
- Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin KBlood, 2000
- Broad screening test for sphingolipid-storage diseasesThe Lancet, 1999
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.Journal of Clinical Investigation, 1994